Skip to content
10-K

Annual Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-17-000052

← back to feed
Filed
Nov 20, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Nov 12, 2017 81.5M sh
Operating Cash Flow FY 2017 · Jun 30, 2017 −$98.75K
Operating Cash Flow FY 2017 · Jun 30, 2016 −$217.76K
Cash And Equivalents FY 2017 · Jun 30, 2017 $5.86K
Cash And Equivalents FY 2017 · Jun 30, 2016 $29.31K
Cash And Equivalents FY 2017 · Jun 30, 2015 $13.77K
Stockholders Equity FY 2017 · Jun 30, 2017 −$53.66K
Stockholders Equity FY 2017 · Jun 30, 2016 −$11.96K
Stockholders Equity FY 2017 · Jun 30, 2015 $22.1K
Current Liabilities FY 2017 · Jun 30, 2017 $62.52K
Current Liabilities FY 2017 · Jun 30, 2016 $75.92K
Current Assets FY 2017 · Jun 30, 2017 $5.86K
Current Assets FY 2017 · Jun 30, 2016 $53.47K
Total Assets FY 2017 · Jun 30, 2017 $8.86K
Total Assets FY 2017 · Jun 30, 2016 $63.96K
Sga Expense FY 2017 · Jun 30, 2017 $97.7K
Sga Expense FY 2017 · Jun 30, 2016 $282.23K
Net Income FY 2017 · Jun 30, 2017 −$117K
Net Income FY 2017 · Jun 30, 2016 −$267.36K
Gross Profit FY 2017 · Jun 30, 2017 −$19.3K
Gross Profit FY 2017 · Jun 30, 2016 $14.87K
Cost Of Revenue FY 2017 · Jun 30, 2017 $25.15K
Cost Of Revenue FY 2017 · Jun 30, 2016 $46.34K
Revenue FY 2017 · Jun 30, 2017 $5.85K
Revenue FY 2017 · Jun 30, 2016 $61.22K